<DOC>
	<DOCNO>NCT01678521</DOCNO>
	<brief_summary>Inflammation play major role atherosclerosis . Pentraxin 3 ( PTX3 ) multifunctional pattern-recognition protein , express many tissues/cells , include innate immunity cell , endothelium atherosclerotic plaque . Its role controversial : may exert protective cardiovascular effect and/or may indicator plaque vulnerability future cardiovascular risk . LDL-Apheresis remove apoB100-containing lipoprotein prevent progression coronary artery disease ( CAD ) . LDL-Apheresis exerts non-lipidic beneficial effect procoagulatory state hemorheology . No data exist effect LDL-Apheresis plasma PTX3 level .</brief_summary>
	<brief_title>Effect LDL-apheresis PTX3 Plasma Levels Hypercholesterolemic Patients</brief_title>
	<detailed_description>Hypercholesterolemic patient document CAD , chronic fortnightly LDL-apheresis treatment enrol study . Blood sample collect single LDL-Apheresis treatment ass PTX3 , HsCRP , IL6 , IL10 , Fibrinogen lipid plasma level .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Hypercholesterolemia document CAD chronic LDLapheresis treatment mental incapacity , unwillingness language barrier preclude adequate understanding cooperation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>LDL-apheresis</keyword>
	<keyword>Coronary artery disease</keyword>
	<keyword>PTX3</keyword>
	<keyword>CRP</keyword>
	<keyword>IL6</keyword>
	<keyword>IL10</keyword>
</DOC>